HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Anabuki Selected Research

MT-3014

1/2020Antipsychotic-like effects of a novel phosphodiesterase 10A inhibitor MT-3014 in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Anabuki Research Topics

Disease

2Type 2 Diabetes Mellitus (MODY)
12/2012 - 10/2012
1Cognitive Dysfunction
01/2020
1Catalepsy
01/2020
1Schizophrenia (Dementia Praecox)
01/2020
1Hyperglycemia
12/2012
1Dyslipidemias (Dyslipidemia)
12/2012
1Hypoglycemia (Reactive Hypoglycemia)
10/2012

Drug/Important Bio-Agent (IBA)

23- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA
12/2012 - 10/2012
2Dipeptidyl-Peptidase IV InhibitorsIBA
12/2012 - 10/2012
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2020
1ProlactinIBA
01/2020
1Antipsychotic Agents (Antipsychotics)IBA
01/2020
1MT-3014IBA
01/2020
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
10/2012
1ThiazolidinesIBA
10/2012

Therapy/Procedure

1Glycemic Control
12/2012